✦ LIBER ✦

Mechanisms of COX-2 inhibitors a possible link to CV events?

Book ID: 120853758
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2005
Weight: 120 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200514920-00049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

COX-2 inhibitors: increased risk of CV e

COX-2 inhibitors: increased risk of CV events?

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 155 KB

Proposed risk of CV events with COX-2 in

Proposed risk of CV events with COX-2 inhibitors debated

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 143 KB

Is it possible to make a Cox-2 inhibitor

Is it possible to make a Cox-2 inhibitor that's safe?

📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 202 KB

Inducible COX-2 dominates over COX-1 in

Inducible COX-2 dominates over COX-1 in prostacyclin biosynthesis: Mechanisms of COX-2 inhibitor risk to heart disease

✍ Cheng-Huai Ruan; Shui-Ping So; Ke-He Ruan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 358 KB

Aldehydes mediate tissue factor inductio

Aldehydes mediate tissue factor induction: A possible mechanism linking lipid peroxidation to thrombotic events

✍ Anna Cabré; Josefa Girona; Joan-C. Vallvé; Lluís Masana 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

Tissue factor (TF), which is expressed in atherosclerotic plaques and colocalizes with oxidized lipids, initiates the thrombogenic process. We have analyzed the effect of aldehydes derived from peroxidation of polyunsaturated fatty acids on TF expression in human vascular smooth muscle cells (HVSMC)

A pathogenetic mechanism for COX-2 inhib

A pathogenetic mechanism for COX-2 inhibitor-induced cardiovascular events proposed to be useful in structuring medical testimony in rofecoxib trials

✍ H.R. Hellstrom 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 118 KB